Published in Pediatr Res on July 01, 1982
Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J Clin Invest (1991) 1.74
Role of epithelial HCO3⁻ transport in mucin secretion: lessons from cystic fibrosis. Am J Physiol Cell Physiol (2010) 1.56
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44
A rational approach to the nutritional care of patients with cystic fibrosis. J R Soc Med (1989) 1.35
Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Gut (1985) 1.18
Cystic fibrosis--a gastroenterological cornucopia. Gut (1987) 1.11
Pathophysiology of the exocrine pancreas in cystic fibrosis. J R Soc Med (1989) 1.04
Mucociliary transport in porcine trachea: differential effects of inhibiting chloride and bicarbonate secretion. Am J Physiol Lung Cell Mol Physiol (2012) 0.93
Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways. Am J Pathol (2012) 0.92
Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis. Gut (1986) 0.87
MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients. Br J Radiol (2010) 0.86
Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr (2003) 0.85
An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis. Pancreatology (2011) 0.85
Pancreatic and biliary secretion are both altered in cystic fibrosis pigs. Am J Physiol Gastrointest Liver Physiol (2012) 0.84
Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J (Clin Res Ed) (1983) 0.83
Normal mucus formation requires cAMP-dependent HCO3- secretion and Ca2+-mediated mucin exocytosis. J Physiol (2013) 0.80
Acid-base transport systems in gastrointestinal epithelia. Gut (1992) 0.79
Ion transport mechanisms linked to bicarbonate secretion in the esophageal submucosal glands. Am J Physiol Regul Integr Comp Physiol (2011) 0.79
Mechanisms of bicarbonate secretion: lessons from the airways. Cold Spring Harb Perspect Med (2012) 0.79
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev (1998) 4.38
Rat intestinal microvillus membranes. Purification and biochemical characterization. Biochem J (1968) 3.66
Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol (1997) 3.06
Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol (1999) 2.78
The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med (1995) 2.49
Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet (1992) 2.48
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22
Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med (1990) 2.06
Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci (2001) 2.03
Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03
Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma (2000) 1.97
A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr (2000) 1.93
Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol (1998) 1.93
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77
Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75
Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology (1988) 1.75
Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem (2000) 1.72
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
The HIV information project for transfusion recipients a decade after transfusion. Arch Pediatr Adolesc Med (1995) 1.70
Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65
Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr (2005) 1.64
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64
(1-14C)glucosamine incorporation by subcellular fractions of small intestinal mucosa. Identification by precursor labeling of three functionally distinct glycoprotein classes. J Biol Chem (1970) 1.57
Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp Neurol (1998) 1.56
Goblet cell mucin of rat small intestine. Chemical and physical characterization. Can J Biochem (1973) 1.55
Total energy expenditure, body fatness, and physical activity in children aged 6-9 y. Am J Clin Nutr (2001) 1.53
Energy expenditure of patients with cystic fibrosis. J Pediatr (1987) 1.51
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50
Acute pancreatitis in childhood. J Pediatr (1988) 1.49
Antigenic and structural features of goblet-cell mucin of human small intestine. Biochem J (1984) 1.48
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet (2009) 1.47
CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet (1995) 1.47
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45
A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44
Release of intestinal surface-membrane glycoproteins associated with enzyme activity by brief digestion with papain. Biochem J (1971) 1.42
Heterogeneity of rat goblet-cell mucin before and after reduction. Biochem J (1983) 1.42
Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41
Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J (1984) 1.40
Iron status of young Vietnamese children in Australia. J Paediatr Child Health (2004) 1.40
Lipid composition of the isolated rat intestinal microvillus membrane. Biochem J (1968) 1.40
Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol Cell Biol (1999) 1.39
Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37
Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
Role of infant feeding practices in development of Crohn's disease in childhood. BMJ (1989) 1.32
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31
Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30
HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol (1998) 1.29
Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28
Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28
cDNA for the carboxyl-terminal region of a rat intestinal mucin-like peptide. J Biol Chem (1992) 1.28
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Accidental paracetamol overdosing and fulminant hepatic failure in children. Med J Aust (1999) 1.26
Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26
Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25
Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species. J Clin Invest (1979) 1.24
Synthesis of intestinal glycoprotein. Incorporation of (I- 14 C) glucosamine in vitro. Biochim Biophys Acta (1971) 1.23
Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene. Am J Hum Genet (2000) 1.23
Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol (1998) 1.22
Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut (1996) 1.22
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet (1992) 1.22
STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : II. PROPERTIES OF THE VIRUS ISOLATED AND PROPAGATED IN CHICK EMBRYOS. J Exp Med (1945) 1.21
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Characterization and localization of the putative 'link' component in rat small-intestinal mucin. Biochem J (1987) 1.20
Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol (2001) 1.19
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17
Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology (1999) 1.17
Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr (1978) 1.16
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16
Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res (1996) 1.16
Enhancement of the viscosity of mucin by serum albumin. Biochem J (1978) 1.14
Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study. Pediatr Infect Dis J (1987) 1.12
Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr (1996) 1.12
Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clin Cancer Res (1998) 1.11
Late gastrointestinal bleeding and protein loss after distal small-bowel resection in infancy. J Pediatr Gastroenterol Nutr (1989) 1.11
Abnormal epithelial transport in cystic fibrosis jejunum. Am J Physiol (1991) 1.10